The purinergic molecules often highlighted as playing key roles in inflammation and immunity, namely A2A, P2X7, P2Y2, CD39 and CD73 [81], are also those associated with the promotion or prevention of GVHD [26,82]. This evidence concerns the gene NT5E and graft versus host disease.